Archynetys Live news trend intelligence
↑ Rising Health

Drinking 2-3 Cups of Coffee Daily Linked to 43% Lower Risk of Liver Cancer

Your daily coffee could cut liver cancer risk by nearly half.

4sources
4articles
4velocity
-38%since first seen
6h agofirst detected
Text:
🤖 AI Dossier

Evidence dossier

Intelligence passport

52/100 Publishable
4distinct sources shown
7velocity measurements
1language editions checked
All brief claims passed the second-source checkbrief evidence status

Measured timeline

Questions people are asking

What daily coffee intake is linked to the lower liver‑cancer risk?

The reports specify two to three cups per day.

By how much does the risk appear to decrease?

The coverage cites a 43 % lower risk of liver cancer.

Which outlets highlighted the study’s findings?

AOL.com reported the statistic; Woman’s World and Yahoo Health described the perk; Parade Magazine mentioned oncologists’ comments.

What happened

⚡ Executive Intelligence Takeaways Corroborated across 4 independent newsrooms
  • Velocity & Diffusion: Coverage exploded across 4 distinct news outlets with 4 published articles, achieving a live velocity of 4.
  • Primary Driver: Your daily coffee could cut liver cancer risk by nearly half.
  • Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.

Imagine feeling reassured that your daily coffee ritual might shield you from a serious disease. A new analysis finds that drinking two to three cups of coffee each day is associated with a 43 % lower risk of liver cancer, turning the popular morning boost into a potential health safeguard.

The finding flips the usual caution about caffeine, suggesting a surprising benefit tied directly to a modest, habit‑forming dose. AOL.com reported the 43 % figure and highlighted the study’s focus on moderate consumption.

Woman’s World and Yahoo Health echoed the surprise, framing the result as a perk of the morning cup, while Parade Magazine noted that oncologists cited the data when discussing liver‑cancer prevention. The coverage stops short of claiming causation, leaving readers to wonder whether upcoming trials will verify the protective effect across diverse groups.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 14m ago.

The reporting (4)

Velocity

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

📊 AUDIENCE & LONGEVITY PULSE

How do you expect this trend to evolve over the next 24 hours?

Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.

Topics

From around our network

Related trends

Open prediction lab

Can you beat the machine?

Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.

Make a prediction →